Corindus Vascular Robotics is in the robotic-assisted precision vascular intervention systems industry. They design, manufacture, and sell robotic systems for use in interventional vascular procedures. Corindus came to my attention during one of my screens because of its change in trend earlier this year. During the spring of this year the stock around support along the 200 day moving average. As the stock moved higher and the 50 day moving average crossed above the 200 day moving average, the stock found new support just above the 50 day moving average. This signaled for me a significant and sustainable move higher. My conclusion has been to start a small position and see where it goes.
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force and distributor relationships in the United States and internationally. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. The company is headquartered in Waltham, Massachusetts.
(Summary) (Company) (Chart)
| 9 August 2017 Price $1.78 1yr Target $3.00 Analysts 1 Dividend $0.00 Payout Ratio 0.00% 1yr Cap Gain 68.53% Yield 0.00% 1yr Tot Return 68.53% P/E --- PEG --- Beta --- | EPS (ttm) $-0.29 EPS next yr $-0.19 Forward P/E --- EPS next 5yr --- 1yr Price Support --- Market Cap $323.33 Mil Revenues $2.50 Bil Earnings $-35.30 Mil Profit Margin --- Quick Ratio 4.70 Current Ratio 4.90 Debt/Equity 0.07 | 1yr RevGR 4.14% 3yr RevGR --- 5yr RevGR --- 1yr EarnGR --- 3yr EarnGR --- 5yr EarnGR --- 1yr DivGR --- 3yr DivGR --- 5yr DivGR --- ROA -123.80% ROE -182.90% |
| |
Print 
PDF
RSS Feed
